» Authors » Tim Littlewood

Tim Littlewood

Explore the profile of Tim Littlewood including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 504
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pilotte N, Omballa V, Voss M, Padgett L, Manuel M, Goodman J, et al.
PLoS Negl Trop Dis . 2025 Jan; 19(1):e0012760. PMID: 39792930
Background: Historically, soil-transmitted helminth (STH) control and prevention strategies have relied on mass drug administration efforts targeting preschool and school-aged children. While these efforts have succeeded in reducing morbidity associated...
2.
Bain B, Littlewood T, Rees D
Br J Haematol . 2021 Dec; 197(3):381-382. PMID: 34961949
No abstract available.
3.
Means A, Asbjornsdottir K, Mwandawiro C, Rollinson D, Jacobson J, Littlewood T, et al.
PLoS Negl Trop Dis . 2016 Jul; 10(7):e0004737. PMID: 27416062
No abstract available.
4.
Hay D, Hill M, Littlewood T
BMJ . 2014 Sep; 349:g5340. PMID: 25214496
No abstract available.
5.
King A, Eyre T, Littlewood T
BMJ . 2013 Dec; 347:f7340. PMID: 24322178
No abstract available.
6.
Thomas D, Hinchliffe R, Briggs C, Macdougall I, Littlewood T, Cavill I
Br J Haematol . 2013 Apr; 161(5):639-648. PMID: 23573815
No abstract available.
7.
Eyre T, Schwab C, Kinstrie R, McGuire A, Strefford J, Peniket A, et al.
Blood . 2012 Nov; 120(22):4441-3. PMID: 23175662
No abstract available.
8.
Medd P, Monk I, Danby R, Malladi R, Clifford R, Ellis A, et al.
Int J Hematol . 2011 Sep; 94(3):266-278. PMID: 21898174
We investigated the contributions of methotrexate (MTX) and ciclosporin (CsA) prophylaxis to acute/chronic graft-versus-host disease (a/cGvHD) prevention following reduced-intensity conditioned allogeneic haematopoietic stem cell transplant (HSCT). Ninety-two fludarabine-melphalan sibling allo-SCT...
9.
Roy N, Myerson S, Schuh A, Bignell P, Patel R, Wainscoat J, et al.
Br J Haematol . 2011 Jun; 154(4):521-4. PMID: 21689086
Transfusion-dependent myelodysplastic (MDS) patients are prone to iron overload. We evaluated 43 transfused MDS patients with T2* magnetic resonance imaging scans. 81% had liver and 16·8% cardiac iron overload. Liver...
10.
Cahill T, Chowdhury O, Myerson S, Ormerod O, Herring N, Grimwade D, et al.
Circulation . 2011 Mar; 123(10):e370-2. PMID: 21403118
No abstract available.